Cardiomyopathies
0
Pipeline Programs
4
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Rocket PharmaceuticalsPKP2-ACM Natural History Study
ZollHeart Rate Monitor Enhanced Treatment Optimization
Clinical Trials (2)
Total enrollment: 36 patients across 2 trials
PKP2-ACM Natural History Study
Start: Mar 2026Est. completion: Apr 203136 patients
N/ARecruiting
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Start: Mar 2021Est. completion: Dec 2024
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 36 patients
4 companies competing in this space